Projects per year
Personal profile
Education
- 2010 PhD, Department of Clinical, Social and Administrative Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA
Experience
- 2010/8-2011/7 Postdotoral research fellow, College of Pharmacy, University of Michigan, Ann Arbor, MI University of Michigan, Michigan, USA
- 2011/08 ~ 2012/07 Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, South Dakota State University, USA
- 2012/08 ~ 2017/01 Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences & Department of Pharmacy, College of Medicine, National Cheng Kung University
- 2017/02~ present Associate Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences & Department of Pharmacy, College of Medicine, National Cheng Kung University
Research Interests
- Pharmacoeconomics
- Patient-reported outcomes
- Pharmacoepidemiology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 1 No Poverty -
SDG 3 Good Health and Well-being -
SDG 5 Gender Equality -
SDG 9 Industry, Innovation, and Infrastructure -
SDG 10 Reduced Inequalities
Fingerprint
Dive into the research topics where Huang-Tz Ou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 8 Finished
-
-
-
建構創新糖尿病疾病預測與成本效益模型，以提供台灣於疾病照護與健保政策之參酌：應用機器學習與模型方法於臨床大數據之研究
Ou, H.-T. (PI)
19-08-01 → 20-07-31
Project: Research project
-
-
-
Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma (PharmacoEconomics, (2025), 43, 4, (429-440), 10.1007/s40273-024-01462-z)
Ou, H. T., Tsai, J. H., Chen, Y. L., Wu, T. I., Chen, L. J. & Yang, S. C., 2026 Feb, In: PharmacoEconomics. 44, 2, p. 261 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Depression following the initiation of glucagon-like-peptide-1 receptor agonist therapy: A multinational self-controlled case series study
Yan, V. K. C., Peng, Z. Y., Wong, V. K. C., Wong, I. C. K., Chan, E. W. Y., Ou, H. T. & Wan, E. Y. F., 2026 Jun, In: Journal of Internal Medicine. 299, 6, p. 776-780 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Detecting anxiety and depression among infertile patients undergoing IVF-ET using the fertility quality of life and the patient health questionnaire-4 tools
Taiwan HPA FertiQoL Research Task Force, 2026 Dec, In: BMC psychology. 14, 1, 755.Research output: Contribution to journal › Article › peer-review
Open Access -
Kidney Effectiveness and Safety of Adding Spironolactone in Patients With Type 2 Diabetes Receiving Renin–Angiotensin System Inhibitors Therapy
Lin, W. R., Huang, T. S., Chang, H. H., Chao, J.-Y., Chang, Y. H., Yang, C. Y., Ou, H. T. & Lin, W.-H., 2026 Mar, In: Clinical and Translational Science. 19, 3, e70509.Research output: Contribution to journal › Article › peer-review
Open Access -
A comparative analysis of biologics market dynamics in 12 countries: (Bio)similar and sustainability
Song, Y., Shin, G., Choi, G., Han, E., Ou, H. T. & Bae, S. J., 2025, In: Frontiers in Pharmacology. 16, 1659395.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus)